119 related articles for article (PubMed ID: 18616207)
1. [Systemic treatment of metastatic colorectal cancer].
Montemurro M; Achtari L; Röth A; Halkic N; Luthi F; Ozsahin M; Denys A; Bauer J; Demartines N; Leyvraz S
Rev Med Suisse; 2008 May; 4(158):1254-7. PubMed ID: 18616207
[TBL] [Abstract][Full Text] [Related]
2. [Chemotherapy for metastatic colorectal cancer].
Iwasa S; Shimada Y
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1467-74. PubMed ID: 18799899
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for colorectal cancer in the metastatic and adjuvant setting: past, present and future.
Sabharwal A; Kerr D
Expert Rev Anticancer Ther; 2007 Apr; 7(4):477-87. PubMed ID: 17428169
[TBL] [Abstract][Full Text] [Related]
4. Integration of biologic agents with cytotoxic chemotherapy in metastatic colorectal cancer.
Jain VK; Hawkes EA; Cunningham D
Clin Colorectal Cancer; 2011 Dec; 10(4):245-57. PubMed ID: 21729675
[TBL] [Abstract][Full Text] [Related]
5. Intermittent therapy in the palliative treatment of metastatic colorectal cancer.
Wadhawan A; Stephens R; Adams R
Expert Rev Anticancer Ther; 2009 Jan; 9(1):125-34. PubMed ID: 19105712
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for colorectal cancer liver metastases.
Alberts SR; Wagman LD
Oncologist; 2008 Oct; 13(10):1063-73. PubMed ID: 18838438
[TBL] [Abstract][Full Text] [Related]
7. Treatment of metastatic colorectal cancer: from cytotoxic agents to molecular agents and multitargeted strategies.
Saif MW; Kang SP; Chu E
Oncology (Williston Park); 2006 Dec; 20(14 Suppl 10):11-9. PubMed ID: 17354513
[TBL] [Abstract][Full Text] [Related]
8. Understanding the predictive role of K-ras for epidermal growth factor receptor-targeted therapies in colorectal cancer.
Ramos FJ; Macarulla T; Capdevila J; Elez E; Tabernero J
Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S52-7. PubMed ID: 19064407
[TBL] [Abstract][Full Text] [Related]
9. Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials.
O'Neil BH; Goldberg RM
Oncologist; 2008 Oct; 13(10):1074-83. PubMed ID: 18922828
[TBL] [Abstract][Full Text] [Related]
10. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
Benoist S; Nordlinger B
Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377
[TBL] [Abstract][Full Text] [Related]
11. A decade of advances in cytotoxic chemotherapy for metastatic colorectal cancer.
Lucas AS; O'Neil BH; Goldberg RM
Clin Colorectal Cancer; 2011 Dec; 10(4):238-44. PubMed ID: 21820973
[TBL] [Abstract][Full Text] [Related]
12. [Second-line chemotherapy for colorectal cancer].
Komatsu Y; Sogabe S; Kawamoto Y; Iwanaga I; Uehata Y; Yuki S; Asaka M
Gan To Kagaku Ryoho; 2009 May; 36(5):721-5. PubMed ID: 19461170
[TBL] [Abstract][Full Text] [Related]
13. Systemic treatment of patients who have colorectal cancer and inflammatory bowel disease.
Goessling W; Mayer RJ
Gastroenterol Clin North Am; 2006 Sep; 35(3):713-27. PubMed ID: 16952747
[TBL] [Abstract][Full Text] [Related]
14. Updated options for liver-limited metastatic colorectal cancer.
Alberts SR
Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S58-62. PubMed ID: 19064408
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
[TBL] [Abstract][Full Text] [Related]
16. The role of salvage treatment in advanced colorectal cancer.
Capdevila J; Ramos FJ; Macarulla T; Elez E; Tabernero J
Crit Rev Oncol Hematol; 2009 Jul; 71(1):53-61. PubMed ID: 18977669
[TBL] [Abstract][Full Text] [Related]
17. Current Opinion on Optimal Treatment Choices in First-line Therapy for Advanced or Metastatic Colorectal Cancer: Report From the Adelaide Colorectal Tumour Group Meeting; Stockholm, Sweden; September 2008.
Price TJ; Tebbutt NC; Karapetis CS; Segelov E; Pavlakis N; Cunningham D; Sobrero AF; Haller DG; Shapiro JD
Clin Colorectal Cancer; 2010 Jan; 9(1):8-14. PubMed ID: 20100683
[TBL] [Abstract][Full Text] [Related]
18. Introduction: Advances in treatment of metastatic colorectal cancer.
Folprecht G
Cancer Treat Rev; 2008; 34 Suppl 2():S1-2. PubMed ID: 19101402
[No Abstract] [Full Text] [Related]
19. Clinical benefit of new targeted agents in phase I trials in patients with advanced colorectal cancer.
Arkenau HT; Brunetto AT; Barriuso J; Olmos D; Eaton D; de Bono J; Judson I; Kaye S
Oncology; 2009; 76(3):151-6. PubMed ID: 19169046
[TBL] [Abstract][Full Text] [Related]
20. The role of UFT in metastatic colorectal cancer.
Bennouna J; Saunders M; Douillard JY
Oncology; 2009; 76(5):301-10. PubMed ID: 19299903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
